Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 1998

View Archived Issues

Possible therapeutic strategy for atherosclerosis: interruption of CD40 signaling

Platelet activity after coronary thrombolysis with reteplase and alteplase

SQ-29548 protects against COX inhibitor-associated postischemic cardiac dysfunction

Novel antiasthmatic TYB-2285 reported to inhibit late asthmatic response and histamine release

Rights to rhFIX gene for use in gene therapy available from BTG

Wyeth-Ayerst to market Abelcet in Greece

Ergo Science completes enrollment of phase II Ergoset clinical study for obesity

Texas Biotechnology reports additional positive phase IIa trial results for TBC-11251

Inhibitor of IgE antibody production discovered by Asahi Chemical

Aronex expands clinical development program for Atragen

Gelatinase inhibitors in development by Kotobuki

Bronchodilators with a pyrrolopyrazolopyrimidine structure patented by Pola

Novavax extends option agreement with Cantab

Dainippon claims series with potential for urinary incontinence

Protein farnesyltransferase inhibitors from Kyowa Hakko

Roche: Q2 1998 highlights

Potassium channel-blocking immunosuppressants from Merck & Co.

KRH-594: profile of a new angiotensin II receptor antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...